BG Medicine, Inc. company info

CIK 1407038
IRS Number 043506204
State of incorporation DE
Business address 610N LINCOLN STREET
Mail address 610N LINCOLN STREET

Short summary

BG Medicine, Inc. is a Massachusetts company, with head office located at 610N Lincoln Street Waltham, Massachusetts 02451. In 2015 the company owned a total of 2.13 million USD worth of assets, including 1.95 million USD worth of current assets. 2010 was the year when the company amassed the most assets.

BG Medicine, Inc. Income Statement

Name [in Millions USD]20082009201020112012201320142015Trends
Revenue, Net 3.682.79
Selling, General and Administrative Expense 7.528.1010.50
Research and development 8.536.548.007.583.742.391.77
Operating Income (Loss) -15.99-14.61-17.49-22.73-14.37-7.36-4.63
Interest expense 0.242.790.
Other Nonoperating Income (Expense) -0.030.23-
Net income -17.11-18.20-17.70-23.77-15.85-8.06-5.30

BG Medicine, Inc. Balance Sheet

Name [in Millions USD]20082009201020112012201320142015Trends
Cash and cash equivalents 20.053.6518.4022.8216.207.754.121.53
Accounts Receivable, Net, Current
Inventories 0.230.310.270.550.300.15
Property, Plant and Equipment, Gross 5.284.980.870.750.48
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment 4.984.790.680.630.47
Intangible Assets, Net (Excluding Goodwill) 0.500.410.330.160.110.08
Total assets 34.0425.5118.3211.241.372.13
Current assets 33.1424.6817.6910.801.151.95
Accounts payable 0.801.021.661.010.610.56
Total current liabilities
Long-term Debt, Excluding Current Maturities 8.575.140.75
Deferred Revenue, Noncurrent 0.23
Total liabilities 5.1416.8914.337.263.741.52
Common Stock, Value, Issued
Retained Earnings (Accumulated Deficit) -103.71-127.38-147.34-157.29-164.38-166.31

BG Medicine, Inc. Cash Flow

Name [in Millions USD]20082009201020112012201320142015Trends
Net income -17.11-18.20-17.70-23.77-15.85-8.06-5.30
Depreciation 0.460.340.
Amortization of Intangible Assets
Depreciation and amortization 0.750.540.420.
Accounts receivable 0.280.51-0.670.28-0.08-0.150.16
Net Cash Provided by (Used in) Operating Activities -17.98-11.42-14.97-21.33-15.29
Payments to Acquire Property, Plant, and Equipment 0.090.13
Payments to Acquire Productive Assets 0.700.
Net Cash Provided by (Used in) Investing Activities 7.511.98-0.09-0.09-0.03
Net Cash Provided by (Used in) Investing Activities, Continuing Operations -0.09-0.030.01
Proceeds from Issuance of Long-term Debt 10
Proceeds from Issuance of Common Stock
Net Cash Provided by (Used in) Financing Activities -1.243.5236.5110.3310.29
Cash and Cash Equivalents, Period Increase (Decrease) -11.71-5.9221.45-11.09-5.04-3.63